Michiel Van Speybroeck appointed Chief Scientific Officer

27 June 2013 – Michiel Van Speybroeck appointed Chief Scientific Officer

Formac Pharmaceuticals is glad to announce the appointment of Michiel Van Speybroeck as Chief Scientitic Officer. Michiel Joined Formac in January 2012 as R&D Director and has since been instrumental in maturing the silica based drug delivery platorm. His expertise in the field has supported major achievements for the company and will further help in establishing Formac as a reliable drug delivery partner.